2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Tóm tắt
Từ khóa
Tài liệu tham khảo
Simonneau G Galiè N Rubin LJ Langleben D Seeger W Domenighetti G Gibbs S Lebrec D Speich R Beghetti M . Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(Suppl 1):S5–S12.
McGoon MD Benza RL Escribano-Subias P Jiang X Miller DP Peacock AJ Pepke-Zaba J Pulido T Rich S Rosenkranz S Suissa S Humbert M . Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol 2013;62(Suppl):D51–D59.
Simonneau G Robbins I Beghetti M Channick RN Delcroix M Denton CP Elliott CG Gaine S Gladwin MT Jing ZC Krowka MJ Langleben D Nakanishi N Souza R . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(Suppl):S43–S54.
Badesch BD Champion HC Gomez-Sanchez MA Hoeper M Loyd J Manes A McGoon M Naeije R Olschewski H Oudiz R Torbicki A . Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(Suppl):S55–S56.
Seeger W Adir Y Barberà JA Champion H Coghlan JG Cottin V De Marco T Galiè N Ghio S Gibbs S Martinez FJ Semigran MJ Simonneau G Wells AU Vachiéry JL . Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013;62(Suppl):D109–D116.
Soubrier F Chung WK Machado R Grunig E Aldred M Geraci M Loyd JE Elliott CG Trembath RC Newman JH Humbert M . Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2013;62(Suppl):D13–D21.
Eyries, 2014, EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension, Nat Genet, 46, 65, 10.1038/ng.2844
Meng, 2013, [A comparison of ventilation/perfusion single photon emission CT and CT pulmonary angiography for diagnosis of pulmonary embolism], Zhonghua Jie He He Hu Xi Za Zhi, 36, 177
Reichelt, 2008, Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography, Eur J Radiol, 71, 49, 10.1016/j.ejrad.2008.03.016
Naeije, 2003, Hepatopulmonary syndrome and portopulmonary hypertension, Swiss Med Wkly, 133, 163
Kovacs, 2014, Reading pulmonary vascular pressure tracings, How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med, 190, 252, 10.1164/rccm.201402-0269PP
Barst R McGoon M Torbicki A Sitbon O Krowka MJ Olschewski A Gaine S . Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(Suppl 1):S40–S47.
Opitz, 2003, Assessment of the vasodilator response in primary pulmonary hypertension, Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J, 24, 356
McLaughlin VV Gaine SP Howard LS Leuchte HH Mathier MA Mehta S Palazzini M Park MH Tapson VF Sitbon O . Treatment goals of pulmonary hypertension. J Am Coll Cardiol 2013;62(Suppl):D73–D81.
Galiè N Simonneau G . The Fifth World Symposium on Pulmonary Arterial Hypertension. J Am Coll Cardiol 2013;62(Suppl):D1–D3.
Galiè N Corris P Frost A Girgis R Granton J Jing ZC Klepetko W McGoon M McLaughlin VV Preston RJ Rubin LJ Sandoval J Seeger W Keogh AM . Updated treatment algorithm of pulmonary hypertension. J Am Coll Cardiol 2013;62(Suppl):D60–D72.
Weitzenblum, 1985, Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, 131, 493, 10.1164/arrd.1985.131.4.493
Preston, 2014, Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL), Am J Respir Crit Care Med, 189, A2464
Singh, 2006, A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension, Am Heart J, 151, 851, 10.1016/j.ahj.2005.09.006
Jones, 1995, Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades, Mol Pharmacol, 48, 890
Rubin, 1990, Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol), Results of a randomized trial. Ann Intern Med, 112, 485, 10.7326/0003-4819-112-7-485
Badesch, 2000, Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease, A randomized, controlled trial [see comments]. Ann Intern Med, 132, 425
Doran, 2008, Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension, Int J Clin Pract Suppl, 160, 5, 10.1111/j.1742-1241.2008.01811.x
Hoeper, 2006, Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension, Eur Respir J, 4, 691, 10.1183/09031936.06.00057906
Galiè, 2015, Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension, New Engl J Med, 379, 834, 10.1056/NEJMoa1413687
McLaughlin VV Channick R Chin KM Frey A Gaine S Ghofrani A Hoeper M Lang I Preiss R Rubin LJ Simonneau G Sitbon O Stefani M Tapson V Galiè N . Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study. J Am Coll Cardiol 2015;65(Suppl A):A380.
Sandoval, 1998, Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension, A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol, 32, 297
Keogh A Benza RL Corris P Dartevelle P Frost A Kim NH Lang I Pepke-Zaba J Sandoval J Mayer E . Interventional and surgical modalities of treatment in pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(Suppl):S67–S77.
Christie JD Edwards LB Kucheryavaya AY Benden C Dipchand AI Dobbels F Kirk R Rahmel AO Stehlik J Hertz MI . The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report—2012. J Heart Lung Transplant 2012;31:1073–1086.
Daliento, 1998, Eisenmenger syndrome, Factors relating to deterioration and death. Eur Heart J, 19, 1845
Hopkins, 1996, Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome, J Heart Lung Transplant, 15, 100
van Albada, 2008, Pulmonary arterial hypertension in congenital cardiac disease—the need for refinement of the Evian-Venice classification, Cardiol Young, 18, 10, 10.1017/S1047951107001849
Lopes AA Leary PW . Measurement, interpretation and use of hemodynamic parameters. Cardiol Young 2009;19(Suppl 1):8–12.
Gatzoulis, 2007, Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study, Int J Cardiol, 127, 27, 10.1016/j.ijcard.2007.04.078
O'Callaghan, 2011, Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases, Presse Med, 40, e65
Demling, 1981, Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep, Am J Physiol, 240, H348
Zopey, 2013, Transition from hepatopulmonary syndrome to portopulmonary hypertension: a case series of 3 patients, Case Rep Pulmonol, 2013, 561870
Raevens, 2013, Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation, Eur J Gastroenterol Hepatol, 25, 495, 10.1097/MEG.0b013e32835c504b
Opravil, 1997, HIV-associated primary pulmonary hypertension, A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med, 155, 990
McMurray, 2012, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J, 33, 1787
Oswald-Mammosser, 1995, Prognostic factors in COPD patients receiving long-term oxygen therapy, Importance of pulmonary artery pressure. Chest, 107, 1193
Guerin, 2014, Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Prevalence of CTEPH after pulmonary embolism. Thromb Haemost, 112, 598, 10.1160/TH13-07-0538
2001, Recommendations on the management of pulmonary hypertension in clinical practice, Heart, 86, I1
Ghofrani HA Distler O Gerhardt F Gorenflo M Grunig E Haefeli WE Held M Hoeper MM Kahler CM Kaemmerer H Klose H Kollner V Kopp B Mebus S Meyer A Miera O Pittrow D Riemekasten G Rosenkranz S Schranz D Voswinckel R Olschewski H . Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011;154(Suppl 1):S20–S33.